CRISPR Therapeutics General Counsel James R. Kasinger disposes of common shares worth $626,459.6

Bitget2026/09/24 21:35

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

James R. Kasinger, general counsel and secretary, sold 10,400 common shares on Sept. 22 at USD 60.2365.
Transaction followed an option exercise for 10,400 shares at USD 13.62 on the same day.
Directly held common shares fell to 94,784 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-401237), on September 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CRISPR Therapeutics General Counsel James R. Kasinger disposes of common shares worth $626,459.6

You may also like

Crypto prices